Thomas Hartung, M.D., Ph.D.
Johns Hopkins School of Public Health
Presentation: Economics of Animal Testing
Thomas Hartung, M.D., Ph.D., is the new director of the Center for Alternatives to Animal Testing (CAAT) and the inaugural Doerenkamp-Zbinden Chair for Evidence-Based Toxicology in the Department of Environmental Health Sciences at the Johns Hopkins University Bloomberg School of Public Health.
Dr. Hartung received his doctorate in biochemical pharmacology in 1991 from the University of Konstanz, Germany, and an medical degree in toxicology in 1992 from the University of Tubingen. He completed his medical internship in surgery at the University of Freiburg.
Dr. Hartung joined the faculty at University of Konstanz in 1994, where he served as an assistant professor of biochemical pharmacology until 1999, and then as an associate professor until 2002. He has been an honorary full professor of pharmacology at Konstanz since 2003. From 1996 to 2002, Dr. Hartung also served as CEO of the Steinbeis Technology Transfer Center for In Vitro Pharmacology and Toxicology (InPuT).
In 2002, Dr. Hartung became head of the European Centre for Alternative Methods (ECVAM) at the European Commission Joint Research Centre in Italy. As head of ECVAM, he was integral in accelerating the alternative methods validation process, and in establishing a network of more than 400 experts from all stakeholder groups to facilitate global regulatory harmonization in toxicity testing.